Fig. 4: Phenotypic characterization of CB-iMGs derived from CB-MNCs exposed to maternal SARS-CoV-2 infection. | Translational Psychiatry

Fig. 4: Phenotypic characterization of CB-iMGs derived from CB-MNCs exposed to maternal SARS-CoV-2 infection.

From: Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure

Fig. 4

a Phase contrast ramified morphology of patient-derived CB-iMGs. Scale bar: 30 μm. b Immunostained images of exposed CB-iMG cells with nuclei (Hoechst) and indicated microglial markers (i) IBA1, (ii) CX3CR1, (iii) P2RY12, and (iv) PU.1. Scale bar: 25 μm.

Back to article page